Lion Street Advisors’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$565K	Buy	14,677 +5,619	+62%	+$633K	0.2%	101
2025 Q2	$946K	Sell	9,058 -489	-5%	-$51.8K	0.29%	80
2025 Q1	$1.11M	Sell	9,547 -52	-0.5%	-$5.92K	0.35%	60
2024 Q4	$812K	Buy	9,599 +1,344	+16%	+$124K	0.26%	86
2024 Q3	$742K	Sell	8,255 -60	-0.7%	-$5.24K	0.26%	84
2024 Q2	$669K	Sell	8,315 -3,617	-30%	-$268K	0.25%	88
2024 Q1	$950K	Hold	11,932	–	–	0.39%	51
2023 Q4	$950K	Sell	11,932 -2,350	-16%	-$157K	0.39%	51
2023 Q3	$998K	Sell	14,282 -620	-4%	-$46.3K	0.33%	59
2023 Q2	$574K	Sell	14,902 -230	-2%	-$17K	0.19%	99
2023 Q1	$933K	Buy	15,132 +1,955	+15%	+$128K	0.29%	59
2022 Q4	$507K	Sell	13,177 -135	-1%	-$8.07K	0.27%	61
2022 Q3	$590K	Buy	13,312 +135	+1%	+$6.75K	0.29%	45
2022 Q2	$513K	Buy	13,177 +75	+0.6%	+$2.37K	0.27%	60
2022 Q1	$538K	Sell	13,102 -75	-0.6%	-$2.33K	0.28%	57
2021 Q4	$503K	Hold	13,177	–	–	0.25%	64
2021 Q3	$433K	Buy	+13,177	New	+$514K	0.23%	70